tradingkey.logo
tradingkey.logo
Search

Mind Medicine Subordinate Voting Ord Shs

DFTX
Add to Watchlist
43.740USD
-0.550-1.24%
Market hours ETQuotes delayed by 15 min
4.55BMarket Cap
LossP/E TTM

Earnings Forecast

Currency: USD Updated:
Previous score
0.00
Change
0

Analyst Rating

Based on 16 analysts
Buy
Current Rating
56.000
Target Price
+26.98%
Upside Space
Strong Buy
Buy
Hold
Sell
Strong Sell

Peer Comparison

567
Total
5
Median
6
Average
Company name
Ratings
Analysts
Mind Medicine Subordinate Voting Ord Shs
DFTX
16
Beigene Ltd
ONC
28
CRISPR Therapeutics AG
CRSP
27
argenx SE
ARGX
26
Ionis Pharmaceuticals Inc
IONS
26
IQVIA Holdings Inc
IQV
25
1
2
3
...
114

Support & Resistance

Relevant data have not been disclosed by the company yet.

Financial Forecasting

EPS
Revenue
Net Profit
EBIT
Forecast
Actual

FAQs

How have Mind Medicine Subordinate Voting Ord ShsDFTX's recent earnings per share performed?

The market expectation was USD -0.71, while Mind Medicine Subordinate Voting Ord ShsDFTX's earnings per share (EPS) for the previous quarter was USD -0.50. EPS for the next quarter is expected at USD -0.56.

What is the analyst rating for Mind Medicine Subordinate Voting Ord Shs?

Based on the ratings of Mind Medicine Subordinate Voting Ord Shs's stock from 16 analysts, most analysts support a Buy trend. After considering the opinions of other analysts, we ultimately rate Apple's stock as Buy. Please note that this is not trading advice. You still need to conduct your own analysis.
tradingkey.logo
* References, analysis, and trading strategies are provided by the third-party provider, Trading Central, and the point of view is based on the independent assessment and judgement of the analyst, without considering the investment objectives and financial situation of the investors.
Risk Warning: Our Website and Mobile App provides only general information on certain investment products. Finsights does not provide, and the provision of such information must not be construed as Finsights providing, financial advice or recommendation for any investment product.
Investment products are subject to significant investment risks, including the possible loss of the principal amount invested and may not be suitable for everyone. Past performance of investment products is not indicative of their future performance.
Finsights may allow third party advertisers or affiliates to place or deliver advertisements on our Website or Mobile App or any part thereof and may be compensated by them based on your interaction with the advertisements.
© Copyright: FINSIGHTS MEDIA PTE. LTD. All Rights Reserved.